Nick Havercroft – CEO & Founder Bioneb
“Speed trumps perfection”
Dr Michael Ryan, Executive Director, WHO Health Emergencies Programme
Viruses cause most upper respiratory tract infections (URTIs), such as Coronavirus adenovirus, coxsackievirus, influenza virus, parainfluenza virus, respiratory syncytial virus, and rhinovirus, which account for the majority of cases.
A broad-spectrum antiviral agent that really works is needed to combat over 200 viruses that cause URTIs.
Undoubtedly Bioneb’s Natural Herbal formulations fits this bill.
Emerging medical studies confirm the stellar, broad-spectrum virotoxic efficacy of Bioneb’s patent-pending formulation both when nebulised .
This includes some of the most formidable viral organisms and collective authoritative medical literature has documented
efficacy of natural herbal formulations virotoxicity against over 24 viruses.
Bioneb’s natural formulation’s antimicrobial efficacy extends well beyond its virotoxicity and its lethal effects span across all microbial domains (viral, bacterial, and fungal).
If it gets access to RNA/ DNA or the Mitochondria – it will denature DNA, denature protein destroy the energy production
system and the microbe, or virus will die preventing all mutation and reproduction of the virus.
Because Viruses, Bacteria, Fungi, Parasites have a primitive membrane and easy access.
Bioneb’s formulation has to be delivered to the site of the infection or it will not be effective, I.E , the mouth, throat and lungs.
The lungs are the most efficient way to deliver medication, 2500km of capillaries, a surface ares the size of two tennis courts.
Five litres of blood pass through the lungs per minute, therefor the distribution of silver ions and nanoparticles and the ability to locate and attack the infected cells of virus and bacteria is instant
Because it can not get through the Eukaryotic (Mammalian) cell, phospholipid bilayer – its too big.(5 times the size of sodium)
And there is no Ag+ membrane protein ion channel. “Healthy cells have good boundaries”